Alternative polyadenylation associated with prognosis and therapy in colorectal cancer

被引:0
|
作者
Yi Zhang
Yunfei Xu
Yuzhi Wang
机构
[1] People’s Hospital of Deyang City,Department of Blood Transfusion
[2] Chengdu Women’s and Children’s Central Hospital,Department of Laboratory Medicine
[3] People’s Hospital of Deyang City,Department of Laboratory Medicine
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Colorectal cancer (CRC) is among the most widely spread cancers globally. Aberrant alternative polyadenylation (APA) plays a role in cancer onset and its progression. Consequently, this study focused on highlighting the role of APA events and signals in the prognosis of patients with CRC. The APA events, RNA sequencing (RNA-seq), somatic mutations, copy number variants (CNVs), and clinical information of the CRC cohort were obtained from The Cancer Genome Atlas (TCGA) database and UCSC (University of California-Santa Cruz) Xena database. The whole set was sorted into two sets: a training set and a test set in a ratio of 7:3. 197 prognosis-related APA events were collected by performing univariate Cox regression signature in patients with CRC. Subsequently, a signature for APA events was established by least absolute shrinkage and selection operator (LASSO) and multivariate Cox analysis. The risk scores were measured for individual patients on the basis of the signature and patients were sorted into two groups; the high-risk group and the low-risk group as per their median risk scores. Kaplan–Meier curves, principal component analysis (PCA), and time-dependent receiver operator characteristic (ROC) curves revealed that the signature was able to predict patient prognosis effectively and further validation was provided in the test set and the whole set. The high-risk and low-risk groups displayed various distributions of mutations and CNVs. Tumor mutation burden (TMB) alone and in combination with the signature predicted the prognosis of CRC patients, but the gene frequencies of TMBs and CNVs did not change in the low- and high-risk groups. Moreover, immunotherapy and chemotherapy treatments showed different responses to PD-1 inhibitors and multiple chemotherapeutic agents in the low and high-risk groups based on the tumor immune dysfunction and exclusion (TIDE) and genomics of drugs sensitivity in cancer (GDSC) databases. This study may help in understanding the potential roles of APA in CRC, and the signature for prognosis-related APA events can work as a potential predictor for survival and treatment in patients with CRC.
引用
收藏
相关论文
共 50 条
  • [1] Alternative polyadenylation associated with prognosis and therapy in colorectal cancer
    Zhang, Yi
    Xu, Yunfei
    Wang, Yuzhi
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [2] Systemic Analysis of the Prognosis-Associated Alternative Polyadenylation Events in Breast Cancer
    Zhang, Yi
    Wang, Yuzhi
    Li, Chengwen
    Jiang, Tianhua
    FRONTIERS IN GENETICS, 2020, 11
  • [3] Alternative Cleavage and Polyadenylation during Colorectal Cancer Development
    Morris, Adam R.
    Bos, Arnold
    Diosdado, Begona
    Rooijers, Koos
    Elkon, Ran
    Bolijn, Anne S.
    Carvalho, Beatriz
    Meijer, Gerrit A.
    Agami, Reuven
    CLINICAL CANCER RESEARCH, 2012, 18 (19) : 5256 - 5266
  • [4] Post-Transcriptional Dysregulation of microRNA and Alternative Polyadenylation in Colorectal Cancer
    Mao, Zhanrui
    Zhao, Hui
    Qin, Yulan
    Wei, Jianming
    Sun, Jielin
    Zhang, Weiwei
    Kang, Yani
    FRONTIERS IN GENETICS, 2020, 11
  • [5] Prognosis and response to therapy in colorectal cancer
    Walker, J
    Quirke, P
    EUROPEAN JOURNAL OF CANCER, 2002, 38 (07) : 880 - 886
  • [6] Alternative polyadenylation is associated with lower expression of PABPN1 and poor prognosis in non-small cell lung cancer
    Ichinose, Junji
    Watanabe, Kousuke
    Sano, Atsushi
    Nagase, Takahide
    Nakajima, Jun
    Fukayama, Masashi
    Yatomi, Yutaka
    Ohishi, Nobuya
    Takai, Daiya
    CANCER SCIENCE, 2014, 105 (09) : 1135 - 1141
  • [7] Determinants of prognosis and response to therapy in colorectal cancer
    Iqbal S.
    Lenz H.-J.
    Current Oncology Reports, 2001, 3 (2) : 102 - 108
  • [8] Usefulness of BCRP in colorectal cancer prognosis and therapy
    Salagacka, A.
    Balcerczak, E.
    Mirowski, M.
    Pasz-Walczak, G.
    Malewski, T.
    FEBS JOURNAL, 2008, 275 : 69 - 69
  • [9] The role of alternative polyadenylation in cancer progression
    Jain, Buddhi Prakash
    GENE REPORTS, 2018, 12 : 1 - 8
  • [10] The contribution of alternative polyadenylation to the cancer phenotype
    Masamha, Chioniso P.
    Wagner, Eric J.
    CARCINOGENESIS, 2018, 39 (01) : 2 - 10